News
JSPRW
0.1619
+2.47%
0.0039
Weekly Report: what happened at JSPRW last week (0422-0426)?
Weekly Report · 5d ago
Weekly Report: what happened at JSPRW last week (0415-0419)?
Weekly Report · 04/22 11:41
Weekly Report: what happened at JSPRW last week (0408-0412)?
Weekly Report · 04/15 11:32
Weekly Report: what happened at JSPRW last week (0401-0405)?
Weekly Report · 04/08 11:37
JASPER THERAPEUTICS INC <JSPR.O>: EVERCORE ISI INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $65
Reuters · 04/03 11:26
Weekly Report: what happened at JSPRW last week (0325-0329)?
Weekly Report · 04/01 11:34
Weekly Report: what happened at JSPRW last week (0318-0322)?
Weekly Report · 03/25 11:37
Weekly Report: what happened at JSPRW last week (0311-0315)?
Weekly Report · 03/18 11:35
Weekly Report: what happened at JSPRW last week (0304-0308)?
Weekly Report · 03/11 11:31
Jasper Therapeutics Inc: Annual report
Press release · 03/05 23:40
Weekly Report: what happened at JSPRW last week (0226-0301)?
Weekly Report · 03/04 11:35
Jasper Therapeutics Inc <JSPR.OQ> expected to post a loss of $1.61 a share - Earnings Preview
Jasper Therapeutics Inc expected to post a loss of $1.61 a share - Earnings Preview. The company is expected to show change in quarterly revenue when it reports results on March 6. Average analyst rating on the shares is "strong buy"
Reuters · 03/04 11:06
Weekly Report: what happened at JSPRW last week (0219-0223)?
Weekly Report · 02/26 11:50
Weekly Report: what happened at JSPRW last week (0212-0216)?
Weekly Report · 02/19 11:53
Weekly Report: what happened at JSPRW last week (0205-0209)?
Weekly Report · 02/12 11:39
Weekly Report: what happened at JSPRW last week (0129-0202)?
Weekly Report · 02/05 11:50
Weekly Report: what happened at JSPRW last week (0122-0126)?
Weekly Report · 01/29 11:36
Weekly Report: what happened at JSPRW last week (0115-0119)?
Weekly Report · 01/22 11:41
Weekly Report: what happened at JSPRW last week (0108-0112)?
Weekly Report · 01/15 11:37
Weekly Report: what happened at JSPRW last week (0101-0105)?
Weekly Report · 01/08 11:42
More
Webull provides a variety of real-time JSPRW stock news. You can receive the latest news about Jasper Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About JSPRW
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting mast cell driven diseases, such as Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CIndU). It also has ongoing programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as Lower to Intermediate Risk Myelodysplastic Syndrome (LR-MDS), and stem cell transplant conditioning regimens. The Company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (c-Kit) receptor on mast and stem cells. The SCF/c-Kit pathway is a survival signal for mast cells. It is also developing briquilimab as a one-time conditioning therapy for severe combined immunodeficiency (SCID) patients undergoing a second stem cell transplant for which it is conducting a Phase 1/2 clinical trial.